JP2006523087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523087A5 JP2006523087A5 JP2004558049A JP2004558049A JP2006523087A5 JP 2006523087 A5 JP2006523087 A5 JP 2006523087A5 JP 2004558049 A JP2004558049 A JP 2004558049A JP 2004558049 A JP2004558049 A JP 2004558049A JP 2006523087 A5 JP2006523087 A5 JP 2006523087A5
- Authority
- JP
- Japan
- Prior art keywords
- nogo
- nig
- cells
- human
- pbs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0228832.2A GB0228832D0 (en) | 2002-12-10 | 2002-12-10 | Organic compound |
| PCT/EP2003/013960 WO2004052932A2 (en) | 2002-12-10 | 2003-12-09 | Antibody (“11c7”) anti nogo a and its pharmaceutical use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006523087A JP2006523087A (ja) | 2006-10-12 |
| JP2006523087A5 true JP2006523087A5 (https=) | 2007-02-01 |
| JP4504200B2 JP4504200B2 (ja) | 2010-07-14 |
Family
ID=9949456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004558049A Expired - Fee Related JP4504200B2 (ja) | 2002-12-10 | 2003-12-09 | 抗体（“１１ｃ７”）抗ｎｏｇｏａおよびその薬学的使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7785593B2 (https=) |
| EP (1) | EP1572745B1 (https=) |
| JP (1) | JP4504200B2 (https=) |
| KR (1) | KR101215801B1 (https=) |
| CN (1) | CN100384877C (https=) |
| AT (1) | ATE475671T1 (https=) |
| AU (1) | AU2003289998B2 (https=) |
| BR (1) | BR0317161A (https=) |
| CA (1) | CA2509068C (https=) |
| CY (1) | CY1110848T1 (https=) |
| DE (1) | DE60333585D1 (https=) |
| DK (1) | DK1572745T3 (https=) |
| EC (1) | ECSP055849A (https=) |
| ES (1) | ES2349293T3 (https=) |
| GB (1) | GB0228832D0 (https=) |
| IL (1) | IL169018A (https=) |
| MX (1) | MXPA05006265A (https=) |
| NO (1) | NO20053304L (https=) |
| PL (1) | PL210720B1 (https=) |
| PT (1) | PT1572745E (https=) |
| RU (1) | RU2350623C2 (https=) |
| SI (1) | SI1572745T1 (https=) |
| WO (1) | WO2004052932A2 (https=) |
| ZA (1) | ZA200504522B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0228832D0 (en) | 2002-12-10 | 2003-01-15 | Novartis Ag | Organic compound |
| GB0321997D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Ag | Organic compound |
| CA2549956C (en) * | 2003-12-22 | 2016-04-12 | Glaxo Group Limited | Immunoglobulins |
| KR20080030960A (ko) * | 2005-07-05 | 2008-04-07 | 글락소 그룹 리미티드 | Ｎｏｇｏ―ａ에 특이적인 인간화된 항체 및 이의 약제학적용도 |
| GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
| HRP20130699T1 (hr) | 2007-11-02 | 2013-11-22 | Novartis Ag | Poboljšane molekule koje se vežu na nogo-a i njihova farmaceutska uporaba |
| JP2011527317A (ja) * | 2008-07-11 | 2011-10-27 | グラクソ グループ リミテッド | Ｎｏｇｏ−ａアンタゴニストによる筋萎縮性側索硬化症の治療 |
| WO2012004773A1 (en) | 2010-07-09 | 2012-01-12 | Universite De Geneve | New uses of nogo-a inhibitors and related methods |
| KR20150036398A (ko) | 2012-07-05 | 2015-04-07 | 글락소 그룹 리미티드 | 근육위축가쪽경화증의 치료에서의 항ｎｏｇｏａ 항체의 최적 투여 섭생 |
| US9534044B2 (en) * | 2013-02-28 | 2017-01-03 | United Arab Emirates University | Alpha-synuclein antibodies and uses thereof |
| CN105491883B (zh) * | 2013-06-13 | 2018-11-02 | 生物马特里卡公司 | 细胞稳定化 |
| MX2018010445A (es) | 2016-03-01 | 2019-10-17 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Anticuerpos especificos del receptor de poliovirus humano (rvp). |
| WO2021070181A1 (en) | 2019-10-08 | 2021-04-15 | Nectin Therapeutics Ltd. | Antibodies against the poliovirus receptor (pvr) and uses thereof |
| WO2021079002A2 (en) * | 2019-10-24 | 2021-04-29 | Novago Therapeutics Ag | Novel anti-nogo-a antibodies |
| WO2026041734A1 (en) | 2024-08-22 | 2026-02-26 | Novago Therapeutics Ag | Methods for treating neurological disorders using anti-nogo-a antibodies |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308573D0 (en) | 1983-03-29 | 1983-05-05 | British Nuclear Fuels Ltd | Filament impregnating/coating |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5180820A (en) | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
| EP0531472B1 (en) | 1991-03-06 | 2003-08-13 | MERCK PATENT GmbH | Humanized monoclonal antibodies |
| DE69942803D1 (de) | 1998-07-22 | 2010-11-11 | Smithkline Beecham Ltd | Rotein änhelt, und dafür kodierende cdns |
| CZ304224B6 (cs) | 1998-11-06 | 2014-01-15 | Schwab | Monoklonální protilátka |
| CU22921A1 (es) | 1999-11-16 | 2004-02-20 | Centro Inmunologia Molecular | Anticuerpos quimérico, humanizado y el fragmento de tipo fv de cadena sencilla que reconoce el antígeno c2. su uso en el diagnóstico y tratamiento de tumores colorrectales |
| IL150566A0 (en) | 2000-01-12 | 2003-02-12 | Univ Yale | Nucleic acids and polypeptides and nogo-receptor proteins |
| ES2437875T3 (es) | 2001-04-30 | 2014-01-14 | Eli Lilly And Company | Anticuerpos humanizados que reconocen el péptido beta-amiloide |
| DE20110806U1 (de) | 2001-06-29 | 2001-12-20 | Jack Wolfskin Ausrüstung für Draussen GmbH, 65510 Idstein | Zelt |
| EP1461300B1 (en) * | 2001-11-30 | 2011-07-27 | Biogen Idec MA Inc. | Antibodies against monocyte chemotactic proteins |
| GB0228832D0 (en) | 2002-12-10 | 2003-01-15 | Novartis Ag | Organic compound |
| CA2549956C (en) | 2003-12-22 | 2016-04-12 | Glaxo Group Limited | Immunoglobulins |
| US7596225B2 (en) * | 2005-06-30 | 2009-09-29 | Alcatl-Lucent Usa Inc. | Method for refreshing a pairwise master key |
-
2002
- 2002-12-10 GB GBGB0228832.2A patent/GB0228832D0/en not_active Ceased
-
2003
- 2003-12-09 BR BR0317161-2A patent/BR0317161A/pt active Search and Examination
- 2003-12-09 MX MXPA05006265A patent/MXPA05006265A/es active IP Right Grant
- 2003-12-09 KR KR1020057010410A patent/KR101215801B1/ko not_active Expired - Fee Related
- 2003-12-09 US US10/538,201 patent/US7785593B2/en not_active Expired - Fee Related
- 2003-12-09 AT AT03782350T patent/ATE475671T1/de active
- 2003-12-09 PT PT03782350T patent/PT1572745E/pt unknown
- 2003-12-09 SI SI200331887T patent/SI1572745T1/sl unknown
- 2003-12-09 DK DK03782350.7T patent/DK1572745T3/da active
- 2003-12-09 EP EP03782350A patent/EP1572745B1/en not_active Expired - Lifetime
- 2003-12-09 WO PCT/EP2003/013960 patent/WO2004052932A2/en not_active Ceased
- 2003-12-09 ES ES03782350T patent/ES2349293T3/es not_active Expired - Lifetime
- 2003-12-09 RU RU2005121669/13A patent/RU2350623C2/ru not_active IP Right Cessation
- 2003-12-09 DE DE60333585T patent/DE60333585D1/de not_active Expired - Lifetime
- 2003-12-09 AU AU2003289998A patent/AU2003289998B2/en not_active Ceased
- 2003-12-09 CA CA2509068A patent/CA2509068C/en not_active Expired - Fee Related
- 2003-12-09 CN CNB2003801096228A patent/CN100384877C/zh not_active Expired - Fee Related
- 2003-12-09 PL PL377506A patent/PL210720B1/pl unknown
- 2003-12-09 JP JP2004558049A patent/JP4504200B2/ja not_active Expired - Fee Related
-
2005
- 2005-06-06 IL IL169018A patent/IL169018A/en not_active IP Right Cessation
- 2005-06-10 EC EC2005005849A patent/ECSP055849A/es unknown
- 2005-07-06 NO NO20053304A patent/NO20053304L/no not_active Application Discontinuation
-
2006
- 2006-02-08 ZA ZA200504522A patent/ZA200504522B/en unknown
-
2010
- 2010-06-18 US US12/819,060 patent/US8535666B2/en not_active Expired - Fee Related
- 2010-10-19 CY CY20101100934T patent/CY1110848T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kubo et al. | Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration | |
| JP2006523087A5 (https=) | ||
| RU2448979C2 (ru) | Антитела человека к дельта-подобному лиганду-4 человека | |
| US8940872B2 (en) | Antibody binding specifically to TDP-43 aggregate | |
| RU2447449C2 (ru) | Модуляторы нейрональной регенерации | |
| US20100322948A1 (en) | Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same | |
| KR102223464B1 (ko) | Ｔ 세포 활성화 저해제, 이것을 함유하는 의약 조성물 및 ｔ 세포 활성화 저해 물질의 스크리닝 방법 | |
| CA2777691A1 (en) | Monoclonal antibodies to progastrin and their uses | |
| MX2010011717A (es) | Anticuerpos anti-hepcidina y metodos de uso. | |
| AU2010335950A1 (en) | Method for decreasing immunogenicity | |
| BR112020003628A2 (pt) | anticorpo anti-pacap | |
| AU2009246443A1 (en) | Anti-PirB antibodies | |
| JP3981148B2 (ja) | 軸索再生促進剤 | |
| CN101277974A (zh) | 排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途 | |
| AU2007320657B8 (en) | Antibody recognizing C-domain of midkine | |
| US20100297147A1 (en) | Compositions and methods for modulating tlr14 activity | |
| EP3244911B1 (en) | A method for determining a likely effect of a treatment to improve male infertility | |
| EP2968550B1 (en) | Compositions and methods for treating angiogenesis-related disorders | |
| KR20110139736A (ko) | 성장 인자 시그널링을 위한 표적 및 치료 방법 | |
| US20250026856A1 (en) | Method for the treatment of a scleroderma disease | |
| EP2310414B1 (en) | Pax 5 monoclonal antibody | |
| EP3594234A1 (en) | Nav1.9 target polypeptide, antibody and antibody fragment combined with same, and related pharmaceutical composition | |
| Otte et al. | Characterization of a maternal type VI collagen in Xenopus embryos suggests a role for collagen in gastrulation. | |
| JP2008503596A (ja) | ヘパリン結合ペプチド | |
| US20110165623A1 (en) | Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family |